Resultado de búsqueda
Riluzole is a medication used to treat amyotrophic lateral sclerosis and other motor neuron diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form.
- C₈H₅F₃N₂OS
- Rilutek, Tiglutik, Exservan, others
- AU: B3
Su acción consiste en cambiar la actividad de ciertas sustancias naturales en el cuerpo que afectan los nervios y los músculos. ¿Cómo se debe usar este medicamento? La presentación del riluzol es en tableta y suspensión (líquido) para tomar por vía oral. También se presenta en forma de película oral para disolver en la lengua.
Riluzol es un fármaco empleado en el tratamiento de la esclerosis lateral amiotrófica. Atrasa la necesidad de la traqueotomía o la dependencia de ventilación - asistida en pacientes seleccionados y puede incrementar la sobrevivencia por unos 3 a 5 meses. Es comercializado por la firma Sanofi-Aventis .
19 de jun. de 2023 · What is riluzole? Riluzole is used to treat amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. Riluzole is not a cure for ALS, but it may delay progression of the disease and prolong your life. Riluzole may also be used for purposes not listed in this medication guide.
- (8)
Riluzole is used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Riluzole is in a class of medications called benzothiazoles. It works by changing the activity of certain natural substances in the body that affect nerves and muscles.
Riluzole is a glutamate antagonist used to treat amyotrophic lateral sclerosis. A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi.
27 de oct. de 2021 · Abstract. Riluzole, a glutamate release inhibitor, has been in use for the treatment of amyotrophic lateral sclerosis for over two decades since its approval by the Food and Drug Administration. Recently, riluzole has been evaluated in cancer cells and indicated to block cell proliferation and/or induce cell death.